Maipu Medical: Announcement on the company\'s products obtaining EU MDR certification
Maipu Medical: Announcement of Resolutions of the Fifth Meeting of the Third Board of Supervisors
Maipu Medical: Supervisory Board\'s Review Opinions on the 2023 Restricted Stock Incentive Plan Granted Part of the First Vesting Period Ownership List for the First Time
Maipu Medical: Announcement on the Abolition of Restricted Stocks Partially Granted in the 2023 Restricted Stock Incentive Plan but not yet owned
Maipu Medical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the first grant of part of the 2023 Restricted Stock Incentive Plan to Guangzhou Maipu Regenerative Medicine Technology Co., Ltd.
Maipu Medical: Announcement on the 2023 Restricted Stock Incentive Plan for the First Time Granting Part of the Achievement of Vesting Conditions for the First Vesting Period
Maipu Medical: Announcement of Resolutions of the Fifth Meeting of the Third Board of Directors
Maipu Medical: Beijing Zhonglun (Guangzhou) Law Firm\'s Legal Opinion on the Company\'s 2023 Restricted Stock Incentive Plan for the First Time Granting of Part of the First Vesting Period, and the Cancellation of Some Restricted Shares Granted but Not Owned
Maipu Medical: Investor Relations Activity Record Form for September 12, 2024
Maipu Medical: Announcement on Participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Guangdong
Maipu Medical: Announcement on the cancellation of the pledge of some shares of the company\'s actual controller and controlling shareholder
Medprin Regenerative Medical Technologies: Investor relations activity record form, August 19, 2024.
Medprin Regenerative Medical Technologies: Half-year report for the year 2024.
Medprin Regenerative Medical Technologies: Summary of Half-Year Report in 2024.
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd.'s continuous supervision and follow-up report on the first half of 2024 for Guangzhou Mike Bio-Regenerative Medical Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Medprin Regenerative Medical Technologies: Announcement on partial share pledges by the actual controllers and major shareholders of the company.
Medprin Regenerative Medical Technologies: Verification opinion of the listing of restricted shares of Guangzhou Maipep Regenerative Medical Technology Co., Ltd.'s initial public offering by Huatai United Securities Co., Ltd.
Medprin Regenerative Medical Technologies: Notice on the Listing of Partly Restricted Shares Prior to Initial Public Offering
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
No Data
No Data